Services

Venture Capital

Funding is often the single biggest barrier for Medtech founders but capital without structure can be just as dangerous as underfunding. Our Venture Capital Arm provides not only Seed and Series A investment, but also the governance and project oversight required to ensure that funds translate into tangible progress.

We partner with founders to refine strategy, monitor execution, and manage risks with the same discipline used by global venture funds. This means startups don’t just raise money; they raise smart capital that comes with frameworks for accountability, milestone tracking, and investor-ready reporting.

Beyond early-stage investment, we prepare ventures for M&A opportunities and strategic exits, ensuring that when the time comes, they are positioned for maximum valuation and smooth transaction flow. In short, our role is not just to fund but to future-proof ventures from the start.

Regulatory & Quality

Brilliant science often stalls when it collides with regulatory complexity. Medtech innovation lives and dies by its ability to navigate global compliance frameworks; and too many startups underestimate this challenge.

Our Regulatory & Quality Arm provides end-to-end regulatory strategy, from pre-submission guidance and dossier preparation to in-market approvals across Southeast Asia and beyond. We design and oversee clinical trial pathways that align with both regulatory requirements and commercial objectives, ensuring studies are not just scientifically valid, but also positioned to unlock reimbursement and adoption.

We also implement quality management systems (such as ISO 13485 and GMP standards), embedding compliance into the DNA of the company rather than treating it as a last-minute checklist. By doing so, we dramatically increase the chances of first-time approval and smooth market entry, helping founders avoid the costly delays that derail so many Medtech startups.

More

Manufacturing

Moving from prototype to production is where many innovations collapse. A device or diagnostic that works in the lab must also be manufacturable, scalable, and compliant without blowing up costs or timelines.

Through our Manufacturing & CMO Arm, we help ventures design for manufacturability, ensuring that engineering choices from day one consider scalability and cost-effectiveness. We work with vetted contract manufacturers (CMOs) to set up pilot production runs, troubleshoot bottlenecks, and validate processes before committing to full-scale manufacturing.

Crucially, we embed quality systems and supply chain resilience early, aligning with ISO 13485, GMP, and other regulatory frameworks so that products are not only production-ready but also compliant with international standards. The result is a smoother, faster path from prototype to global market readiness.

Clinical

No Medtech innovation can reach patients without robust clinical evidence. Our Clinical Arm ensures that every study is designed, executed, and analyzed to meet both regulatory standards and real-world adoption needs.

We provide end-to-end clinical trial support, beginning with protocol and study design to ensure scientific rigor while balancing cost and time efficiency. Our team manages site selection and investigator engagement, leveraging our hospital and clinician networks across Asia to secure high-quality, reliable trial partners.

From there, we oversee trial execution and monitoring, ensuring compliance with GCP standards and minimizing data variability. Our data management and biostatistics teams deliver validated results and meaningful insights that strengthen regulatory submissions, reimbursement applications, and clinician confidence.

By integrating clinical strategy with regulatory, commercial, and investor considerations, we ensure trials don’t just generate data; they generate evidence that accelerates adoption and investment.

Commercial

Even the best Medtech product fails if it never reaches the hands of doctors, hospitals, or patients. Our Commercial Arm is dedicated to solving this challenge by creating market-ready strategies and execution plans.

We design go-to-market (GTM) strategies that balance pricing, reimbursement, and adoption hurdles, and then actively support execution through our regional networks of distributors, hospitals, and ecosystem partners. Our team also strengthens sales enablement, developing the messaging, training, and clinical evidence required to convince stakeholders.

To ensure adoption, we refine UX and UI, making sure the product fits seamlessly into the workflow of busy clinicians and the lives of patients. By orchestrating commercialization, we don’t just open doors; we ensure products are truly used, trusted, and scaled.

Exit & Growth

For investors and founders alike, the ultimate measure of success is not just product launch but long-term value creation and exit readiness. Our Exit & Growth Arm ensures that from day one, companies are built with scalability and investability in mind.

We prepare ventures for licensing deals, strategic acquisitions, or IPOs, depending on their trajectory. This involves benchmarking company performance, conducting investor-style due diligence internally, and strengthening governance to meet the expectations of global buyers or public markets.

By focusing early on exit pathways, we help ventures avoid dead ends and instead position themselves as attractive, high-multiple opportunities. Whether the goal is acquisition by a global healthcare company, licensing technology across borders, or pursuing IPO, our role is to ensure every option remains open and achievable.